BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34510770)

  • 1. Association of Bethesda category and molecular mutation in patients undergoing thyroidectomy.
    Mascarella MA; Peeva M; Forest VI; Pusztaszeri MP; Avior G; Tamilia M; Mlynarek AM; Hier MP; Payne RJ
    Clin Otolaryngol; 2022 Jan; 47(1):75-80. PubMed ID: 34510770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
    Hier J; Avior G; Pusztaszeri M; Krasner JR; Alyouha N; Forest VI; Hier MP; Mlynarek A; Richardson K; Sadeghi N; Tamilia M; Payne RJ
    J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):29. PubMed ID: 33910629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
    Yaprak Bayrak B; Eruyar AT
    BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules.
    Jooya A; Saliba J; Blackburn A; Tamilia M; Hier MP; Mlynarek A; Forest VI; Rochon L; Florea A; Wang H; Payne RJ
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):51. PubMed ID: 27756425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer.
    Schumm MA; Shu ML; Hughes EG; Nikiforov YE; Nikiforova MN; Wald AI; Lechner MG; Tseng CH; Sajed DP; Wu JX; Yeh MW; Livhits MJ
    JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):735-742. PubMed ID: 37382944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential effects of molecular testing of indeterminate thyroid nodule fine needle aspiration biopsy on thyroidectomy volume.
    Dedhia PH; Rubio GA; Cohen MS; Miller BS; Gauger PG; Hughes DT
    World J Surg; 2014 Mar; 38(3):634-8. PubMed ID: 24435929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
    Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
    Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does bethesda category predict aggressive features in malignant thyroid nodules?
    Kleiman DA; Beninato T; Soni A; Shou Y; Zarnegar R; Fahey TJ
    Ann Surg Oncol; 2013 Oct; 20(11):3484-90. PubMed ID: 23812773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
    Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
    JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
    Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
    Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mcgill thyroid nodule score - does it help with indeterminate thyroid nodules?
    Varshney R; Forest VI; Mascarella MA; Zawawi F; Rochon L; Hier MP; Mlynarek A; Tamilia M; Payne RJ
    J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):2. PubMed ID: 25645364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Genetics Augment Cytopathologic Evaluation and Surgical Planning of Pediatric Thyroid Nodules.
    Spaulding SL; Maayah M; Dinauer CA; Prasad M; Darbinyan A; Morotti R; Christison-Lagay ER
    J Pediatr Surg; 2024 May; 59(5):975-980. PubMed ID: 38246817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative detection of RAS mutation may guide extent of thyroidectomy.
    Patel SG; Carty SE; McCoy KL; Ohori NP; LeBeau SO; Seethala RR; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2017 Jan; 161(1):168-175. PubMed ID: 27863786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.
    Morand GB; Tessler I; Noik M; Krasner J; Yamin T; Pusztaszeri MP; Avior G; Payne RJ
    Endocr Pract; 2024 Apr; 30(4):319-326. PubMed ID: 38184241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy Rates by Bethesda Subcategory in the Pediatric Population.
    Park S; Osterbauer B; Sahyouni G; Paik C; Austin J; Gomez G; Shillingford N; Kwon D
    Pediatr Dev Pathol; 2022; 25(6):598-603. PubMed ID: 35861469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles.
    Elsherbini N; Kim DH; Payne RJ; Hudson T; Forest VI; Hier MP; Payne AE; Pusztaszeri MP
    J Otolaryngol Head Neck Surg; 2022 Nov; 51(1):43. PubMed ID: 36371345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between the Bethesda system for thyroid nodules and post-thyroidectomy histopathological diagnosis].
    Kraus-Fischer G; Alvarado-Bachmann R; Rienzo-Madero B; Núñez-García E; Peña MV; Zerrweck-López C
    Rev Med Inst Mex Seguro Soc; 2020 Apr; 58(2):114-121. PubMed ID: 34101555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.
    Yip L; Wharry LI; Armstrong MJ; Silbermann A; McCoy KL; Stang MT; Ohori NP; LeBeau SO; Coyne C; Nikiforova MN; Bauman JE; Johnson JT; Tublin ME; Hodak SP; Nikiforov YE; Carty SE
    Ann Surg; 2014 Jul; 260(1):163-8. PubMed ID: 24901361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules.
    Buryk MA; Monaco SE; Witchel SF; Mehta DK; Gurtunca N; Nikiforov YE; Simons JP
    Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1697-700. PubMed ID: 23993207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.